216 related articles for article (PubMed ID: 8897161)
21. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
22. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
Cavazza S; Lagging M
Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
[TBL] [Abstract][Full Text] [Related]
23. Performance of third-generation confirmatory tests for detection of antibody to hepatitis C virus.
Chaudhary RK; Jacobsen H
J Clin Microbiol; 1994 Oct; 32(10):2606-8. PubMed ID: 7529244
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
[TBL] [Abstract][Full Text] [Related]
25. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to a novel antigen in acute hepatitis C virus infections.
Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
[TBL] [Abstract][Full Text] [Related]
28. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
[TBL] [Abstract][Full Text] [Related]
29. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus.
Abdel-Hamid M; El-Daly M; El-Kafrawy S; Mikhail N; Strickland GT; Fix AD
J Clin Microbiol; 2002 May; 40(5):1656-9. PubMed ID: 11980937
[TBL] [Abstract][Full Text] [Related]
30. Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.
Yeh CT; Han CM; Lo SY; Ou JH; Fan KD; Sheen IS; Chu CM; Liaw YF
J Clin Microbiol; 1994 Sep; 32(9):2235-41. PubMed ID: 7529251
[TBL] [Abstract][Full Text] [Related]
31. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
Engel PM; Dennin RH
Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
[TBL] [Abstract][Full Text] [Related]
32. Immune responses of blood donors to peptides of various lengths and those with genotypic sequence variations corresponding to the N-terminal portion of the core protein of hepatitis C virus.
Sato A; Sho Y; Nakamura H; Kunitomo T; Arima T
J Med Virol; 1994 Sep; 44(1):88-91. PubMed ID: 7528261
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
[TBL] [Abstract][Full Text] [Related]
35. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.
Bresters D; Zaaijer HL; Cuypers HT; Reesink HW; Winkel IN; van Exel-Oehlers PJ; van Drimmelen AA; Jansen PL; van der Poel CL; Lelie PN
Transfusion; 1993 Aug; 33(8):634-8. PubMed ID: 7688158
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of hepatitis C infection among blood donors in northeastern Thailand.
Songsivilai S; Jinathongthai S; Wongsena W; Tiangpitayakorn C; Dharakul T
Am J Trop Med Hyg; 1997 Jul; 57(1):66-9. PubMed ID: 9242321
[TBL] [Abstract][Full Text] [Related]
37. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
[TBL] [Abstract][Full Text] [Related]
38. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
[TBL] [Abstract][Full Text] [Related]
39. Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR.
Siemoneit K; da Silva Cardoso M; Wölpl A; Epple S; Wintersinger H; Koerner K; Kubanek B
Ann Hematol; 1994 Sep; 69(3):129-33. PubMed ID: 8086507
[TBL] [Abstract][Full Text] [Related]
40. An algorithm for confirming screen reactivity in blood donors in enzyme immunoassays for antibodies to hepatitis C virus.
Craske J; Paver WK; Farmer D
J Immunol Methods; 1993 Apr; 160(2):227-35. PubMed ID: 7681460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]